Cargando…
Evaluation of Integrin α(v)β(3) Expression in Murine Xenograft Models: [(68)Ga]Ga-DOTA-C(RGDfK) PET Study with Immunohistochemical Confirmation
Tumor blood flow (TBF) is related to drug delivery and hypoxia, both of which can impact the efficacy of anti-cancer therapies. Although integrin α(v)β(3) expression is related to tumor angiogenesis, it remains unclear whether the degree of angiogenesis affects TBF. This study aimed to evaluate the...
Autores principales: | Mitsuyuki, Kosuke, Watabe, Tadashi, Naka, Sadahiro, Liu, Yuwei, Tatsumi, Mitsuaki, Shimosegawa, Eku, Kato, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307120/ https://www.ncbi.nlm.nih.gov/pubmed/34359378 http://dx.doi.org/10.3390/diagnostics11071295 |
Ejemplares similares
-
Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [(68)Ga]Ga-DOTA-E-[c(RGDfK)](2) PET/CT
por: Lobeek, D., et al.
Publicado: (2020) -
(68)Ga-DOTA-E-[c(RGDfK)]2 positron emission
tomography–computed tomography in the evaluation of hepatic hemangioendothelioma
epithelioid
por: Soldevilla-Gallardo, Irma, et al.
Publicado: (2019) -
Preparation and preclinical evaluation of a (68)Ga-labelled c(RGDfK) conjugate comprising the bifunctional chelator NODIA-Me
por: Läppchen, Tilman, et al.
Publicado: (2018) -
Synthesis of Novel, Dual-Targeting (68)Ga-NODAGA-LacN-E[c(RGDfK)](2) Glycopeptide as a PET Imaging Agent for Cancer Diagnosis
por: Gyuricza, Barbara, et al.
Publicado: (2021) -
[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020)